Category: Anti PD-1 Melanoma
-
Relative Roles of Targeted Therapies and Immunotherapies in Melanoma
Anti PD1. Dr. Mario Sznol is Professor of Medicine at the Yale School of Medicine and the clinical Research Program Leader of the Yale Cancer Center’s Melanoma Program. In this interview, Dr. Sznol shares unique insights into these two treatment approaches, including how they compare and how they might be combined